ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,595
-0,20%
Bitcoin
66 273,94
0,00%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Panacea Acquisition Corp (NUVB)

  7. Panacea Acquisition Corp (NUVB) Actualités

NUVB

Panacea Acquisition (NUVB)

Panacea Acquisition Corp
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:NUVB
DateHeureSourceTitreSymboleSociété
14/05/202422h28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NUVBPanacea Acquisition Corp
14/05/202422h20Edgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
14/05/202422h05Business WireNuvation Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
24/04/202416h01Business WireNuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:NUVBPanacea Acquisition Corp
10/04/202422h01Business WireNuvation Bio Completes Acquisition of AnHeart TherapeuticsNYSE:NUVBPanacea Acquisition Corp
28/03/202413h00Business WireNuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial OfficerNYSE:NUVBPanacea Acquisition Corp
25/03/202412h00Business WireNuvation Bio to Acquire AnHeart Therapeutics in All-Stock TransactionNYSE:NUVBPanacea Acquisition Corp
14/03/202421h05Business WireNuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid TumorsNYSE:NUVBPanacea Acquisition Corp
04/03/202423h30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NUVBPanacea Acquisition Corp
04/03/202423h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
29/02/202423h06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:NUVBPanacea Acquisition Corp
29/02/202422h01Business WireNuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
10/01/202422h21Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
08/01/202422h58Dow Jones NewsNuvation Bio Gets New Drug Application Clearance From FDA for Solid Tumor TreatmentNYSE:NUVBPanacea Acquisition Corp
08/01/202422h10Business WireNuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of DirectorsNYSE:NUVBPanacea Acquisition Corp
08/01/202422h05Business WireNuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid TumorsNYSE:NUVBPanacea Acquisition Corp
13/11/202322h05Business WireNuvation Bio Announces Departure of Chief Financial OfficerNYSE:NUVBPanacea Acquisition Corp
02/11/202321h10Business WireNuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
03/08/202322h10Business WireNuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
01/06/202322h05Business WireNuvation Bio Announces Formation of Oncology-Focused Scientific Advisory BoardNYSE:NUVBPanacea Acquisition Corp
17/05/202323h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NUVBPanacea Acquisition Corp
16/05/202322h04Edgar (US Regulatory)Current Report Filing (8-k)NYSE:NUVBPanacea Acquisition Corp
04/05/202322h33Edgar (US Regulatory)Quarterly Report (10-q)NYSE:NUVBPanacea Acquisition Corp
04/05/202322h05Business WireNuvation Bio Reports First Quarter 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
11/04/202322h27Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:NUVBPanacea Acquisition Corp
04/04/202322h10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:NUVBPanacea Acquisition Corp
15/03/202321h05Business WireNuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
14/02/202314h53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:NUVBPanacea Acquisition Corp
13/02/202318h50Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:NUVBPanacea Acquisition Corp
19/12/202222h05Business WireNuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868NYSE:NUVBPanacea Acquisition Corp
 Showing the most relevant articles for your search:NYSE:NUVB

Dernières Valeurs Consultées

ASX
WHFN
BIT
P1KT98
BNP Paribas Issuance
CSE
LAN
Declan Cobalt Inc.
LSE
BC43
Inter-amer 30
TG
DC4
Dexcom
COIN
POMIETH
Pomi Coin
ASX
OSXDA
Osteopore
COIN
RPLKRW
Rocket Pool
BIT
F17210
Vontobel Financial Produ...
BIT
UB78F1
Unicredit Bank
NYSE
AMT.PRB
American Tower Corp NEW
LSE
13AN
Anz Bank 42
LSE
FD76
Int.fin.24
COIN
FGDUST
FGDTOKEN
ASX
SFRKOA
NYSE
BLCO
Bausch plus Lomb
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés